1998
DOI: 10.1111/1468-2230.00177
|View full text |Cite
|
Sign up to set email alerts
|

The Inscription of Life in Law: Genes, Patents, and Bio‐politics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
20
0
1

Year Published

2004
2004
2013
2013

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 86 publications
(21 citation statements)
references
References 0 publications
0
20
0
1
Order By: Relevance
“…Pottage (1998) says that 'The use of a banal doctrinal distinction to disqualify political or ethical objections is quite routine in patent law' (p. 750). In the case of utility, the apparently banal doctrinal understanding of utility in the patenting guidelines is not only open to multiple interpretations, but can also be used to defiect political and ethical objections to patentability and the commercial exploitation of knowledge.…”
Section: Discussionmentioning
confidence: 99%
“…Pottage (1998) says that 'The use of a banal doctrinal distinction to disqualify political or ethical objections is quite routine in patent law' (p. 750). In the case of utility, the apparently banal doctrinal understanding of utility in the patenting guidelines is not only open to multiple interpretations, but can also be used to defiect political and ethical objections to patentability and the commercial exploitation of knowledge.…”
Section: Discussionmentioning
confidence: 99%
“…As the cell line was discontinuous with the person from whom it derived, it could be regarded as a biological invention and warranting a patent. In the early 1990s, the NIH was actively seeking to patent as many inventions as possible, so Jenkins and Gajdusek felt obliged to apply to the US Patent and Trademark Office to become owners of the cell line, which was preserved, frozen in liquid nitrogen, in the American Type Culture Collection (Bhat, 1996;Pottage, 1998). 37 The issue of the patent (number 5,397,696) on the Hagahai cell line on 14 March 1995 quickly became a major salient in the struggle against bioprospecting and the commodification of indigenous bodies.…”
Section: Body Commoditiesmentioning
confidence: 99%
“…Nevertheless, when the bioeconomy is analysed in terms of labour, attention invariably turns to the value created by highly skilled, scientific labour, understood to perform the work of creative innovation necessary to transform biological life into industrial, therapeutic or agricultural processes (Ashish and Gambardella, 1994;Gambardella, 1995). The organization of intellectual property in the life sciences recognizes the cognitive labour of the scientist and the clinician, but not the constitutive nature of the biological material or the collaboration of the donor (Pottage, 1998). It is evident then that the recognition of labour here is structured by a mind/body split, wherein the embodied productivity of the tissue donor does not figure.…”
Section: Labour and The Stem Cell Industriesmentioning
confidence: 99%